Search research articles
Contact Us
Filters
Showing results (201-210 of 218) with videos related to
Page
of 22
Sort By:
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate Cancer
Jie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Cancer Discovery
|
November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
Yi Bao, Gabriel Cruz, Yuping Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
Tongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Cell
|
December 17, 2025
Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses
Diana Castaño, Emily Bettini, Binod Kumar, et al.
Cell Reports. Medicine
|
October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition
Yu Chang, Xiaoju Wang, Jianzhang Yang, et al.
Cell Reports
|
June 20, 2020
STING Gain-of-Function Disrupts Lymph Node Organogenesis and Innate Lymphoid Cell Development in Mice
Brock G Bennion, Carys A Croft, Teresa L Ai, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
Tongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Nature Genetics
|
October 3, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer
Jie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
The Journal of Clinical Investigation
|
September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
Yi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 218) with videos related to
Sort By:
Page
of 22
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate Cancer
Jie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Cancer Discovery
|
November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
Yi Bao, Gabriel Cruz, Yuping Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
Tongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Cell
|
December 17, 2025
Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses
Diana Castaño, Emily Bettini, Binod Kumar, et al.
Cell Reports. Medicine
|
October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition
Yu Chang, Xiaoju Wang, Jianzhang Yang, et al.
Cell Reports
|
June 20, 2020
STING Gain-of-Function Disrupts Lymph Node Organogenesis and Innate Lymphoid Cell Development in Mice
Brock G Bennion, Carys A Croft, Teresa L Ai, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
Tongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Nature Genetics
|
October 3, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer
Jie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
The Journal of Clinical Investigation
|
September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
Yi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Page
of 22